Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cells.
about
The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro.Rev1, Rev3, or Rev7 siRNA Abolishes Ultraviolet Light-Induced Translesion Replication in HeLa Cells: A Comprehensive Study Using Alkaline Sucrose Density Gradient Sedimentation.Caffeine abolishes the ultraviolet-induced REV3 translesion replication pathway in mouse cells.The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 1: post-translational regulation.The proteasome inhibitor lactacystin exerts its therapeutic effects on glioma via apoptosis: an in vitro and in vivo study.Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice.
P2860
Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Proteasome inhibitors remarkab ...... er cells but not normal cells.
@en
type
label
Proteasome inhibitors remarkab ...... er cells but not normal cells.
@en
prefLabel
Proteasome inhibitors remarkab ...... er cells but not normal cells.
@en
P2093
P2860
P1433
P1476
Proteasome inhibitors remarkab ...... er cells but not normal cells.
@en
P2093
Jun Takezawa
Kouichi Yamada
Yukio Ishimi
P2860
P304
P356
10.1111/J.1349-7006.2008.00764.X
P577
2008-02-24T00:00:00Z